<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00291525</url>
  </required_header>
  <id_info>
    <org_study_id>2005-01</org_study_id>
    <secondary_id>G050208</secondary_id>
    <nct_id>NCT00291525</nct_id>
  </id_info>
  <brief_title>Randomized On-X Anticoagulation Trial</brief_title>
  <acronym>PROACT</acronym>
  <official_title>Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>On-X Life Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinipace LTD</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alere, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>On-X Life Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Various patient groups with the On-X Valve can be maintained safely on lower doses of blood
      thinner(Coumadin®) or on antiplatelet drugs (aspirin/Plavix®) only rather than the standard
      dose of Coumadin and aspirin presently recommended by ACC/AHA or ACCP professional societies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a longitudinal, randomized (randomization to occur at the 3-month follow-up) study
      comparing the On-X valve on low dose anticoagulation (test group) to concomitant control
      groups of On-X valves receiving standard Coumadin/aspirin therapy, and also to FDA objective
      performance criteria (OPC) for heart valve replacement. It is a multicenter study consisting
      of up to 50 centers in the United States and Canada enrolling no more than 1200 patients (200
      in each of 6 groups). There are three test arms of the study: low risk aortic valve
      replacement, high risk aortic valve replacement, and mitral valve replacement. Each arm has
      an equivalent control. Test therapies are: low risk aortic valve replacement -
      aspirin/Plavix, high risk aortic valve replacement - Coumadin at INR of 1.5 to 2.0 plus
      aspirin, and mitral valve replacement - Coumadin at an INR of 2.0 to 2.5 plus aspirin.
      Follow-up will run for up to 8 years in each patient. Each arm is independent and the low
      risk aortic and high risk aortic arms are completed. The low risk aortic arm was closed early
      resulting in a reduction of the estimated enrollment to 1000. The high risk arm is completed
      with FDA review and this arm had 375 enrollees. The mitral arm continues to enroll with a
      planned enrollment of 400.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of thromboembolism evaluated every 100 patient-years</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of thrombosis evaluated every 100 patient-years</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of bleeding events evaluated every 100 patient-years</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of other valve related events every 100 patient-years</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional classification at each follow-up</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echo hemodynamics at 1, 3 and 5 years</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Heart Valve Disease</condition>
  <arm_group>
    <arm_group_label>AVR Low Risk without warfarin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AVR Low Risk without warfarin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AVR low risk with standard warfarin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AVR low risk with standard warfarin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AVR High risk with lower warfarin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AVR High risk with lower warfarin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AVR High Risk with standard warfarin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AVR High Risk with standard warfarin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MVR with lower warfarin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MVR with lower warfarin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MVR with standard warfarin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>MVR with standard warfarin</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>On-X valve using reduced anticoagulation</intervention_name>
    <description>Valve replacement with antiplatelet agents or lowered warfarin</description>
    <arm_group_label>AVR Low Risk without warfarin</arm_group_label>
    <arm_group_label>AVR High risk with lower warfarin</arm_group_label>
    <arm_group_label>MVR with lower warfarin</arm_group_label>
    <other_name>On-X Prosthetic Heart Valve</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>On-X Valve with Standard warfarin Therapy</intervention_name>
    <description>Valve replacement with standard dosage warfarin</description>
    <arm_group_label>AVR low risk with standard warfarin</arm_group_label>
    <arm_group_label>AVR High Risk with standard warfarin</arm_group_label>
    <arm_group_label>MVR with standard warfarin</arm_group_label>
    <other_name>On-X Prosthetic Heart Valve</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring isolated aortic valve replacement (AVR), or isolated mitral valve
             replacement (MVR).

          -  AVR patients receiving low dose or antiplatelet only anticoagulation will be divided
             into groups at low risk and high risk for thromboembolism with all patients being in
             the low risk group except for patients with the following conditions which place a
             patient in the high risk group:

               -  Chronic atrial fibrillation

               -  Left ventricular ejection fraction &lt; 30 %

               -  Enlarged left atrium &gt;50mm diameter

               -  Spontaneous echo contrasts in the left atrium

               -  Vascular pathology

               -  Neurological events

               -  Hypercoagulability

               -  Left or right ventricular aneurysm

               -  Lack of platelet response to aspirin or clopidogrel

               -  Women receiving estrogen replacement therapy

          -  Concomitant cardiac surgery is allowed

          -  Adult patients

        Exclusion Criteria:

          -  Right side valve replacement

          -  Double (aortic plus mitral) valve replacement

          -  Patients with active endocarditis at the time of implant

          -  Previous confirmed or suspected thromboembolic event or thrombophlebitis

          -  Other terminal illness

          -  Patients who are in an emergency state

          -  Inability to return for required follow-ups

          -  Patients with an On-X valve implanted within the study and subsequently explanted

          -  Patients who are known to be pregnant, plan to become pregnant or are lactating

          -  Patients with acquired immunodeficiency syndrome or know to be HIV positive

          -  Patients who are prison inmates or known drug or alcohol abusers

          -  Patients unable to give adequate informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Puskas, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gretchen Wilderspin, MS</last_name>
    <phone>678-290-4309</phone>
    <email>wilderspin.gretchen@cryolife.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephen E Ottmers, PhD</last_name>
    <phone>512-580-2254</phone>
    <email>ottmers.stephen@cryolife.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tucson Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulshan Sethi, MD</last_name>
      <phone>520-696-4780</phone>
      <email>gsethi2807@aol.com</email>
    </contact>
    <contact_backup>
      <last_name>Cassaundra Bayless</last_name>
      <phone>520-891-1429</phone>
      <email>cassaundrab@pimaheart.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gulshan Sethi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Arizona VA Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Loma Linda University</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nan Wang, MD</last_name>
      <phone>909-558-4354</phone>
      <email>nwang@llu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dipal Patel, MD</last_name>
      <phone>909-558-0348</phone>
      <email>dpatel@ahs.llumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nan Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hagberg, MD</last_name>
      <phone>860-696-5520</phone>
      <email>Rhagberg@harthosp.org</email>
    </contact>
    <contact_backup>
      <last_name>Arben Ademi</last_name>
      <phone>860-545-3561</phone>
      <email>Aademi@harthosp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Hagberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Health Care Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Shands Hospital - University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cardiac Surgical Associates</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>South Florida Heart &amp; Lung</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Accola, MD</last_name>
      <phone>407-897-5600</phone>
      <email>susan.brettin@flhosp.org</email>
    </contact>
    <contact_backup>
      <last_name>Delores Barnes, RN</last_name>
      <phone>407-303-5600</phone>
      <phone_ext>110-2018</phone_ext>
      <email>delores.b.barnes@flhosp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin Accola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30365</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Puskas, MS</last_name>
      <phone>404-686-2513</phone>
      <email>john_puskas@emoryhealthcare.org</email>
    </contact>
    <contact_backup>
      <last_name>Shannon Smith, BSN</last_name>
      <phone>404-686-2513</phone>
      <email>shannon.smith@emoryhealthcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>John Puskas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Omar Lattouf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Guyton, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Heart Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc W Gerdisch, MD</last_name>
      <phone>317-851-2331</phone>
      <email>mgerdisch@openheart.net</email>
    </contact>
    <contact_backup>
      <last_name>Molly Miller</last_name>
      <phone>317-893-1948</phone>
      <email>Molly.Miller@franciscanalliance.org.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marc W Gerdisch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cotton-O'Neil Clinical Research Center</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reed Quinn, MD</last_name>
      <phone>207-662-6258</phone>
      <email>quinnr@mmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Jane Kane, RN</last_name>
      <phone>207-662-6991</phone>
      <email>kanejan@mmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Reed Quinn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bobby K Kong, MD</last_name>
      <phone>734-712-5500</phone>
      <email>bbkong@comcast.net</email>
    </contact>
    <contact_backup>
      <last_name>Suzanne Winter</last_name>
      <phone>734-712-7509</phone>
      <email>winters@trinity-health.org</email>
    </contact_backup>
    <investigator>
      <last_name>Bobby K Kong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mid America Heart institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital - Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Damiano, MD</last_name>
      <phone>314-747-4404</phone>
    </contact>
    <contact_backup>
      <last_name>Tracey Guthrie</last_name>
      <phone>14-747-4404</phone>
      <email>guthriet@wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ralph Damiano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Mexico Heart Institute</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St. Luke's Roosevelt</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Bello, MD</last_name>
      <phone>718-405-8373</phone>
      <email>rbello@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Meli</last_name>
      <phone>718-920-4747</phone>
      <email>rmeli@montefiore.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ricardo Bello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WakeMed</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gosta Pettersson, MD</last_name>
      <phone>216-444-2035</phone>
      <email>petterg@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Roberta Palumbo</last_name>
      <phone>216-444-8774</phone>
      <email>palumbr@ccf.org</email>
    </contact_backup>
    <investigator>
      <last_name>Gosta Pettersson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma/VA Oklahoma City</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Providence Heart &amp; Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Douville, MD</last_name>
      <phone>503-963-3030</phone>
      <email>ecdouville@orclinic.com</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Dixon</last_name>
      <phone>503-215-6746</phone>
      <email>michelle.dixon@providence.org</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Douville, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinay Badhwar, MD</last_name>
      <phone>412-648-6314</phone>
      <email>badhwarv@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Valchar</last_name>
      <phone>412-647-7271</phone>
      <email>valcharka@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vinay Badhwar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Waits, MD</last_name>
      <phone>214-645-7726</phone>
    </contact>
    <contact_backup>
      <last_name>Mary DeLira</last_name>
      <phone>214-645-7728</phone>
    </contact_backup>
    <investigator>
      <last_name>Michael Wait, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Center</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79410</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Mary Washington Hospital</name>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <zip>22401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael McGrath, MD</last_name>
      <phone>757-622-6344</phone>
    </contact>
    <contact_backup>
      <last_name>Michelle Collier</last_name>
      <phone>757-668-2732</phone>
    </contact_backup>
    <investigator>
      <last_name>Michael McGrath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Barnhart, MD</last_name>
      <phone>206-215-1500</phone>
      <email>Glenn.Barnhart@Swedish.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Nagel</last_name>
      <phone>206-386-6462</phone>
      <email>Jennifer.Nagel@Swedish.org</email>
    </contact_backup>
    <investigator>
      <last_name>Glenn Barnhart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tacoma General Hospital</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Nichols, MD</last_name>
      <phone>253-403-7257</phone>
    </contact>
    <contact_backup>
      <last_name>Janey Barnhart</last_name>
      <phone>253-403-7252</phone>
    </contact_backup>
    <investigator>
      <last_name>Dennis Nichols, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Aurora Health Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>76G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Meyer, MD</last_name>
      <phone>780-407-1959</phone>
      <email>Steven.Meyer@albertahealthservices.ca</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Williams</last_name>
      <phone>780-407-1959</phone>
      <email>Barb.Williams@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Meyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>London Health Science Center</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bob Kiaii, MD</last_name>
      <phone>519-663-3135</phone>
      <email>Bob.Kiaii@lhsc.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Fox</last_name>
      <phone>519-685-8500</phone>
      <phone_ext>35031</phone_ext>
      <email>Stephanie.Fox@LHSC.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Bob Kiaii, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Ruel, MD</last_name>
      <phone>613-761-4893</phone>
      <email>Mruel@OttawaHeart.ca</email>
    </contact>
    <contact_backup>
      <last_name>Gifferd Ko</last_name>
      <phone>613-798-5555</phone>
      <phone_ext>13022</phone_ext>
      <email>gko@ottawaheart.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marc Ruel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IUCPQ Chirurgie Cardiaque</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois Dagenais, MD</last_name>
      <phone>418-656-4717</phone>
      <email>francois.dagenais@fmed.ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>Hugo Tremblay</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>3797</phone_ext>
      <email>hugo.tremblay@criucpq.ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Francois Dagenais, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A; PROACT Investigators. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014 Apr;147(4):1202-1210; discussion 1210-1. doi: 10.1016/j.jtcvs.2014.01.004. Epub 2014 Jan 12.</citation>
    <PMID>24512654</PMID>
  </results_reference>
  <results_reference>
    <citation>Yanagawa B, Levitsky S, Puskas JD; PROACT Investigators. Reduced anticoagulation is safe in high-risk patients with the On-X mechanical aortic valve. Curr Opin Cardiol. 2015 Mar;30(2):140-145. doi: 10.1097/HCO.0000000000000149.</citation>
    <PMID>29504958</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2006</study_first_submitted>
  <study_first_submitted_qc>February 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2006</study_first_posted>
  <last_update_submitted>September 24, 2017</last_update_submitted>
  <last_update_submitted_qc>September 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>valve</keyword>
  <keyword>prosthesis</keyword>
  <keyword>antithrombotics</keyword>
  <keyword>randomized</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

